English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 863809      Online Users : 867
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/7246


    Title: Loss of epithelial membrane protein-2 expression confers an independent prognosticator in gallbladder carcinoma
    Authors: Li, CF;Chen, LT;Lin, CY;Wang, YH;Huang, HY;Hsing, CH;Tsai, CJ;Shiue, YL
    Contributors: National Institute of Cancer Research
    Abstract: The objective of this study was to evaluate the expression of epithelial membrane protein-2 (EMP2) and its clinicopathological associations in patients with gallbladder carcinoma (GBC). A retrospective population-based cohort study was performed based on a biobank from 1986 to 2005. Biopsies of 164 GBC patients without initial distant metastasis were collected during surgical intervention. Immunoexpressions of EMP2 and Ki-67 were analyzed and the outcomes were correlated with clinicopathological features and patient survival. Results indicated that loss of EMP2 expression (50%) was correlated with female patients (p = 0.037), advanced primary tumor (p < 0.017), vascular (p < 0.001), and perineural (p < 0.027) invasions and high Ki-67 labeling index (p < 0.001).In multivariate analysis, loss of EMP2 expression, high Ki-67 labeling index, and age emerged as independent prognosticators for worse disease-specific (p < 0.001; p < 0.001; and p = 0.001, respectively) and disease-free (p = 0.002; p = 0.002; and p = 0.008, respectively) survivals, following by the American Joint Committee on Cancer stage (p < 0.001; p < 0.001; and p < 0.001, respectively). Collectively, loss of EMP2 expression is common and associated with adverse prognosticators and might confer tumor aggressiveness through hampering its interaction with specific membrane protein(s) and antiproliferative activity, and perhaps the downstream signal transduction pathway(s).
    Date: 2013-05
    Relation: Biomarkers and Genomic Medicine. 2013 May;5(1-2):31-38.
    Link to: http://dx.doi.org/10.1016/j.gmbhs.2013.04.004
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84883766327
    Appears in Collections:[陳立宗] 期刊論文

    Files in This Item:

    File Description SizeFormat
    SDO2211425413000083.pdf1719KbAdobe PDF260View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback